• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国有记录糖尿病的成年人的超额死亡率:2013-2014 年德国所有保险索赔的常规数据分析。

Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013-2014.

机构信息

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

出版信息

BMJ Open. 2021 Jan 6;11(1):e041508. doi: 10.1136/bmjopen-2020-041508.

DOI:10.1136/bmjopen-2020-041508
PMID:33408205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789443/
Abstract

OBJECTIVES

Little is known about the age-specific excess mortality pattern of people with diagnosed diabetes in Germany. Thus, our goal was to determine the excess mortality in diagnosed diabetes overall and stratified by age and sex based on claims data.

DESIGN

Routine data analysis using a claims dataset from all statutory health-insured persons in Germany in 2013, which accounts for about 90% of the population.

PARTICIPANTS

We included persons who lived in Germany, were insured at least 360 days, were not self-paying any health services and were aged 30 years or older leading to a total number of 47.3 million insured persons for analyses.

EXPOSURE

Diabetes was determined by the International Classification of Diseases-10 codes E10-E14, which were documented in 2013 in at least two-quarters on an outpatient setting or at least once on an inpatient setting.

OUTCOME MEASURES

The vital status in the study population was drawn from the claims dataset for the year 2014. We derived the excess mortality estimated as an age-adjusted mortality rate ratio (MRR) by sex and for age groups using a Poisson model.

MAIN RESULTS

We found age-adjusted MRRs (95% CI) for diabetes of 1.52 (1.51 to 1.52) for women and 1.56 (1.56 to 1.56) for men. These figures declined with increasing age and were highest for ages 30-34 years with 6.76 (4.99 to 9.15) for women and 6.87 (5.46 to 8.64) for men, and lowest for age 95 years and older with 1.13 (1.10 to 1.15) for women and 1.11 (1.05 to 1.17) for men.

CONCLUSIONS

We derived deeply age-stratified figures on excess mortality in diabetes for Germany. Establishing a sustainable analysis of excess mortality is aimed at within the framework of diabetes surveillance.

摘要

目的

德国关于确诊糖尿病患者特定年龄段超额死亡率的信息知之甚少。因此,我们的目标是根据索赔数据确定总体诊断为糖尿病患者以及按年龄和性别分层的超额死亡率。

设计

使用德国 2013 年所有法定健康保险人员的索赔数据集进行常规数据分析,该数据集涵盖了约 90%的人口。

参与者

我们纳入了居住在德国、至少投保 360 天、不自行支付任何医疗服务费用且年龄在 30 岁及以上的人员,总计有 4730 万被保险人进行分析。

暴露情况

通过国际疾病分类第 10 版(ICD-10)代码 E10-E14 确定糖尿病,这些代码在 2013 年至少有四分之二在门诊或至少一次在住院时记录。

结局测量

研究人群的生存状态从索赔数据集中 2014 年的数据中得出。我们使用泊松模型按性别和年龄组计算了超额死亡率,估计为年龄调整死亡率比(MRR)。

主要结果

我们发现女性的年龄调整 MRR(95%CI)为 1.52(1.51 至 1.52),男性为 1.56(1.56 至 1.56)。这些数字随年龄的增加而下降,在 30-34 岁年龄组最高,女性为 6.76(4.99 至 9.15),男性为 6.87(5.46 至 8.64),在 95 岁及以上年龄组最低,女性为 1.13(1.10 至 1.15),男性为 1.11(1.05 至 1.17)。

结论

我们得出了德国糖尿病超额死亡率的深度年龄分层数据。目标是在糖尿病监测框架内建立对超额死亡率的可持续分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/f9d53a21778c/bmjopen-2020-041508f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/7d4aefa4012f/bmjopen-2020-041508f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/0746a2929d1a/bmjopen-2020-041508f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/f9d53a21778c/bmjopen-2020-041508f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/7d4aefa4012f/bmjopen-2020-041508f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/0746a2929d1a/bmjopen-2020-041508f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c223/7789443/f9d53a21778c/bmjopen-2020-041508f03.jpg

相似文献

1
Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013-2014.德国有记录糖尿病的成年人的超额死亡率:2013-2014 年德国所有保险索赔的常规数据分析。
BMJ Open. 2021 Jan 6;11(1):e041508. doi: 10.1136/bmjopen-2020-041508.
2
[Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany].[基于健康声明数据的德国糖尿病监测参考分析中记录糖尿病的患病率和发病率]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):93-102. doi: 10.1007/s00103-019-03068-9.
3
[Estimating prevalent microvascular complications of diabetes mellitus in Germany. Analysis of statutory health insurance data in 2012 and 2013].[德国糖尿病微血管并发症患病率估算。2012年和2013年法定医疗保险数据分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Oct;63(10):1219-1230. doi: 10.1007/s00103-020-03211-x.
4
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.2012 年至 2021 年德国 2 型糖尿病发病趋势:对 1100 万法定参保人健康索赔数据的分析。
Diabetologia. 2024 Jun;67(6):1040-1050. doi: 10.1007/s00125-024-06113-8. Epub 2024 Feb 26.
5
Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany.归因于确诊糖尿病的死亡率负担:基于德国 6500 万人理赔数据的全国性分析。
Diabetes Care. 2017 Dec;40(12):1703-1709. doi: 10.2337/dc17-0954. Epub 2017 Oct 9.
6
Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.糖尿病——德国的患病率及疾病成本:一项评估德国法定医疗保险数据的研究
Diabet Med. 2006 Mar;23(3):299-305. doi: 10.1111/j.1464-5491.2005.01779.x.
7
Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.德国西南部2型糖尿病的患病率、发病率及合并症——一项基于大型法定医疗保险理赔数据的回顾性队列和病例对照研究
BMC Public Health. 2015 Sep 3;15:855. doi: 10.1186/s12889-015-2188-1.
8
Diabetes 'epidemic' in Germany? A critical look at health insurance data sources.德国的糖尿病“流行”?对健康保险数据源的批判性审视。
Exp Clin Endocrinol Diabetes. 2012 Jul;120(7):410-5. doi: 10.1055/s-0032-1306331. Epub 2012 Mar 22.
9
[Algorithm for the Classification of Type 1 and Type 2 Diabetes Mellitus for the Analysis of Routine Data].[用于常规数据分析的1型和2型糖尿病分类算法]
Gesundheitswesen. 2023 Mar;85(S 02):S119-S126. doi: 10.1055/a-1791-0918. Epub 2022 Jun 2.
10
[Secondary data analysis of the prevalence of alcohol dependence (F10.2) in Germany].[德国酒精依赖症(F10.2)患病率的二次数据分析]
Dtsch Med Wochenschr. 2014 Nov;139(45):2285-9. doi: 10.1055/s-0034-1387353. Epub 2014 Oct 28.

引用本文的文献

1
Modeling the temporal prevalence peak drift of chronic diseases.模拟慢性病的时间流行高峰漂移。
BMC Med Res Methodol. 2025 Mar 7;25(1):65. doi: 10.1186/s12874-025-02517-1.
2
Projecting the economic burden of type 1 and type 2 diabetes mellitus in Germany from 2010 until 2040.预测 2010 年至 2040 年德国 1 型和 2 型糖尿病的经济负担。
Popul Health Metr. 2024 Jul 18;22(1):17. doi: 10.1186/s12963-024-00337-x.
3
Using the illness-death model to estimate age- and sex-standardized incidence rates of diabetes in Mexico from 2003 to 2015.

本文引用的文献

1
Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - A review in the framework of the Diabetes Surveillance.德国成年人糖尿病的患病率、发病率和死亡率——糖尿病监测框架下的综述
J Health Monit. 2017 Oct 9;2(3):98-121. doi: 10.17886/RKI-GBE-2017-062. eCollection 2017 Oct.
2
Secondary data in diabetes surveillance - co-operation projects and definition of references on the documented prevalence of diabetes.糖尿病监测中的二手数据——合作项目及糖尿病记录患病率参考标准的定义
J Health Monit. 2019 Jun 27;4(2):50-63. doi: 10.25646/5988. eCollection 2019 Jun.
3
Global Trends in Type 2 Diabetes, 2007-2017.
利用疾病死亡模型估计 2003 年至 2015 年墨西哥按年龄和性别标准化的糖尿病发病率。
BMC Public Health. 2024 Jul 15;24(1):1882. doi: 10.1186/s12889-024-19281-4.
4
Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes-The MoKaRi II Randomized Controlled Study.验证营养干预对高甘油三酯血症或糖尿病前期患者心血管和糖尿病风险因素的调节作用——MoKaRi II 随机对照研究。
Nutrients. 2024 Apr 24;16(9):1261. doi: 10.3390/nu16091261.
5
Mortality of type 2 diabetes in Germany: additional insights from Gompertz models.德国 2 型糖尿病的死亡率:来自戈珀特模型的更多见解。
Acta Diabetol. 2024 Jun;61(6):765-771. doi: 10.1007/s00592-024-02237-w. Epub 2024 Mar 11.
6
Importance of Diagnostic Accuracy in Big Data: False-Positive Diagnoses of Type 2 Diabetes in Health Insurance Claims Data of 70 Million Germans.大数据中诊断准确性的重要性:7000万德国人的健康保险理赔数据中2型糖尿病的假阳性诊断
Front Epidemiol. 2022 May 23;2:887335. doi: 10.3389/fepid.2022.887335. eCollection 2022.
7
[Development and Internal Validation of Case Definitions for Prevalence Estimation of Microvascular Complications of Diabetes in Routine Data].[糖尿病微血管并发症患病率估计病例定义在常规数据中的制定与内部验证]
Gesundheitswesen. 2024 Jul;86(S 03):S196-S204. doi: 10.1055/a-2061-6954. Epub 2023 May 30.
8
Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.未来 2040 年德国被诊断为 1 型糖尿病的人数预测:基于索赔数据的分析。
BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2022-003156.
9
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.23 个高收入司法管辖区 2 型糖尿病的终生风险、预期寿命和生命损失年数:一项跨国、基于人群的研究。
Lancet Diabetes Endocrinol. 2022 Nov;10(11):795-803. doi: 10.1016/S2213-8587(22)00252-2. Epub 2022 Sep 29.
10
Future prevalence of type 2 diabetes-A comparative analysis of chronic disease projection methods.未来 2 型糖尿病的流行情况——慢性病预测方法的比较分析。
PLoS One. 2022 Mar 7;17(3):e0264739. doi: 10.1371/journal.pone.0264739. eCollection 2022.
2007 - 2017年全球2型糖尿病趋势
JAMA. 2019 Oct 22;322(16):1542. doi: 10.1001/jama.2019.16074.
4
Can Routine Data be used to Determine the Target Population of Patients with Type 2 Diabetes in Early Benefit Assessments in Germany?在德国的早期效益评估中,常规数据能否用于确定2型糖尿病患者的目标人群?
Gesundheitswesen. 2020 Mar;82(S 01):S13-S19. doi: 10.1055/a-0948-5301. Epub 2019 Aug 26.
5
Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants.性别差异与糖尿病与心血管疾病、癌症以及全因和病因特异性死亡率风险之间的关联:一项包含 5162654 名参与者的系统评价和荟萃分析。
BMC Med. 2019 Jul 12;17(1):136. doi: 10.1186/s12916-019-1355-0.
6
Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.2016 年和 2017 年美国成年人确诊 1 型和 2 型糖尿病的患病率:基于人群的研究。
BMJ. 2018 Sep 4;362:k1497. doi: 10.1136/bmj.k1497.
7
Global trends in diabetes complications: a review of current evidence.全球糖尿病并发症趋势:现有证据综述。
Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31.
8
Excess mortality for people diagnosed with type 2 diabetes in 2012 - Estimates based on claims data from 70 million Germans.2012年2型糖尿病确诊患者的超额死亡率——基于7000万德国人的理赔数据估算
Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):887-891. doi: 10.1016/j.numecd.2018.05.008. Epub 2018 May 29.
9
Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.美国有和无诊断糖尿病的成年人特定病因死亡率趋势:基于全国调查和生命统计数据的流行病学分析。
Lancet. 2018 Jun 16;391(10138):2430-2440. doi: 10.1016/S0140-6736(18)30314-3. Epub 2018 May 18.
10
All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany.患有和未患2型糖尿病的成年人的全因死亡率:德国国家健康监测的结果
BMJ Open Diabetes Res Care. 2017 Dec 16;5(1):e000451. doi: 10.1136/bmjdrc-2017-000451. eCollection 2017.